Browsing: Clinical Breakthroughs

A new study has shown that vitamin D supplements do not reduce muscle pain associated with statin drugs.

Even before COVID-19, emergency departments experienced a spike in visits for youth with suicidal thoughts or ideas, according to a recent study.

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University will begin scaling up its collection and use of data related to patient sex assigned at birth, gender identity, and sexual orientation with funding from the National Cancer Institute.

Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.

There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.

A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.

Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.

The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.

A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.

After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.